Clinical Trial Update: Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and tolerability of CBLB502 as a neoadjuvant treatment for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CBLB502

Snippet

Sponsor: BioLab 612 LLC | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN